Related references
Note: Only part of the references are listed.Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors
Andres Morales La Madrid et al.
CURRENT CANCER DRUG TARGETS (2018)
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Amy Lee Bredlau et al.
CURRENT NEUROPHARMACOLOGY (2017)
Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases
Zhihong J. Wang et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
Faizaan Mohammad et al.
NATURE MEDICINE (2017)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience
Andrea Carai et al.
WORLD NEUROSURGERY (2017)
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
Tammy Hennika et al.
PLOS ONE (2017)
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
David A. Solomon et al.
BRAIN PATHOLOGY (2016)
Investigational new drugs for brain cancer
Verena Staedtke et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3
M. Wiese et al.
KLINISCHE PADIATRIE (2016)
The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors
Jiao Chen et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors
Elizabeth Wadhwa et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2016)
Surgical approaches for brainstem tumors in pediatric patients
Sergio Cavalheiro et al.
CHILDS NERVOUS SYSTEM (2015)
Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas
Stephanie Puget et al.
CHILDS NERVOUS SYSTEM (2015)
Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition
Isabella C. Taylor et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Panobinostat active against diffuse intrinsic pontine glioma
Sanjeet Bagcchi
LANCET ONCOLOGY (2015)
Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
Yevgen Chornenkyy et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Function and information content of DNA methylation
Dirk Schuebeler
NATURE (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
Prospects of immune checkpoint modulators in the treatment of glioblastoma
Matthias Preusser et al.
NATURE REVIEWS NEUROLOGY (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma
Nathalene Truffaux et al.
NEURO-ONCOLOGY (2015)
A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent
Kyle G. Halvorson et al.
PLOS ONE (2015)
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Michael Christoph Haffner et al.
Oncotarget (2015)
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M. Saratsis et al.
ACTA NEUROPATHOLOGICA (2014)
Subventricular spread of diffuse intrinsic pontine glioma
Viola Caretti et al.
ACTA NEUROPATHOLOGICA (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
Diffuse intrinsic pontine glioma: a reassessment
Nathan J. Robison et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Strategy for Detoxification of a Cancer-Derived Histone Mutant Based on Mapping Its Interaction with the Methyltransferase PRC2
Zachary Z. Brown et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz et al.
NATURE GENETICS (2014)
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Kathryn R. Taylor et al.
NATURE GENETICS (2014)
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas
Liwei Zhang et al.
NATURE GENETICS (2014)
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso et al.
NATURE GENETICS (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma
Ute Bartels et al.
NEURO-ONCOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomized trial on radiotherapy for paediatric diffuse intrinsic pontine glioma (DIPG)
Daniel E. Roos et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling
Hans-Martin Herz et al.
SCIENCE (2014)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Barbara S. Paugh et al.
CANCER RESEARCH (2013)
Poisoning the histone code in pediatric gliomagenesis
Peter W. Lewis et al.
CELL CYCLE (2013)
Histone variants in pluripotency and disease
Peter J. Skene et al.
DEVELOPMENT (2013)
Motexafin-Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood: A Children's Oncology Group Phase 2 Study
Kristin A. Bradley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhiping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
Viola Caretti et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Chromatin proteins and modifications as drug targets
Kristian Helin et al.
NATURE (2013)
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Jinghui Zhang et al.
NATURE GENETICS (2013)
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas
Lindsay B. Kilburn et al.
NEURO-ONCOLOGY (2013)
Histone Regulation in the CNS: Basic Principles of Epigenetic Plasticity
Ian Maze et al.
NEUROPSYCHOPHARMACOLOGY (2013)
In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma
Susanna J. E. Veringa et al.
PLOS ONE (2013)
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
Kelly L. Barton et al.
PLOS ONE (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Lynn Bjerke et al.
CANCER DISCOVERY (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
Alexandra Borodovsky et al.
ONCOTARGET (2013)
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.
Sevin Turcan et al.
ONCOTARGET (2013)
Re-irradiation with hypo-fractionated stereotactic robotic radiotherapy for salvage in adult patients with brainstem glioma
Sridhar P. Susheela et al.
ECANCERMEDICALSCIENCE (2013)
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Dong-Anh Khuong-Quang et al.
ACTA NEUROPATHOLOGICA (2012)
Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma
Hiral P. Fontanilla et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
Gaspar J. Kitange et al.
CLINICAL CANCER RESEARCH (2012)
The molecular classification of medulloblastoma: driving the next generation clinical trials
Sarah E. S. Leary et al.
CURRENT OPINION IN PEDIATRICS (2012)
Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience
Johannes E. Wolff et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
Katherine E. Warren et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Gordon Li et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas
Stephanie Puget et al.
PLOS ONE (2012)
Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry
Michael H. Chan et al.
PEDIATRIC BLOOD & CANCER (2012)
Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
Brent A. Orr et al.
PLOS ONE (2012)
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde et al.
ACTA NEUROPATHOLOGICA (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Nanoparticle-based Drug Delivery Systems for Solid Brain Tumors
Bin Feng et al.
CURRENT NANOSCIENCE (2011)
Role of adaptive radiation therapy for pediatric patients with diffuse pontine glioma
Chris Beltran et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG
Ute Bartels et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
Atique U. Ahmed et al.
MOLECULAR PHARMACEUTICS (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma
Seung Ah Choi et al.
NEURO-ONCOLOGY (2011)
Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas
Jennifer Barrow et al.
NEURO-ONCOLOGY (2011)
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger et al.
NEURO-ONCOLOGY (2011)
Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas
Daphne A. Haas-Kogan et al.
NEURO-ONCOLOGY (2011)
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium
Ian F. Pollack et al.
NEURO-ONCOLOGY (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells
Ji S. Park et al.
BIOMATERIALS (2010)
Prospective Collection of Tissue Samples at Autopsy in Children With Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
CANCER (2010)
Overview of Cellular Immunotherapy for Patients with Glioblastoma
Elodie Vauleon et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
Sridharan Gururangan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas
Gordon Li et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles
Fan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Characterization and outcomes of infratentorial malignant glioma: A population-based study using the Surveillance Epidemiology and End-Results database
Justin Rineer et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
M. A. Tyler et al.
GENE THERAPY (2009)
BEVACIZUMAB AS THERAPY FOR RADIATION NECROSIS IN FOUR CHILDREN WITH PONTINE GLIOMAS
Arthur K. Liu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma
Leigh Ellis et al.
CLINICAL CANCER RESEARCH (2008)
Natural history and management of brainstem gliomas in adults -: A retrospective Italian study
A. Salmaggi et al.
JOURNAL OF NEUROLOGY (2008)
In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging
Xing Wu et al.
JOURNAL OF NEUROSURGERY (2008)
Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts
Kathleen J. Helton et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2008)
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: A Children's Oncology Group phase I study
Kristin A. Bradley et al.
NEURO-ONCOLOGY (2008)
Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma
Nongnuch Sirachainan et al.
NEURO-ONCOLOGY (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development
Karl Agger et al.
NATURE (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Brainstem tumors: Where are we today?
Pablo F. Recinos et al.
PEDIATRIC NEUROSURGERY (2007)
A novel brainstem tumor model: functional and histopathological characterization
George I. Jallo et al.
CHILDS NERVOUS SYSTEM (2006)
The supratonsillar approach to the inferior cerebellar peduncle:: Anatomy, surgical technique, and clinical application to cavernous malformations
Michael T. Lawton et al.
NEUROSURGERY (2006)
CNS immune privilege: hiding in plain sight
Monica J. Carson et al.
IMMUNOLOGICAL REVIEWS (2006)
Covalently linked au nanoparticles to a viral vector: Potential for combined photothermal and gene cancer therapy
M Everts et al.
NANO LETTERS (2006)
Advances toward an understanding of brainstem gliomas
SS Donaldson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Brainstem gliomas in adults: prognostic factors and classification
JS Guillamo et al.
BRAIN (2001)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Gene therapy of experimental brain tumors using neural progenitor cells
S Benedetti et al.
NATURE MEDICINE (2000)
Share Paper
